While Namenda as been demonstrated to be of some benefit for moderate-severe Alzheimer's disease, several circumstances have recently led to the unavailability of either the immediate release form or the extended release form. This presents a difficult problem for patients who have bee taking the medication and new patients who would like to begin taking the medication. Dr. Trista Bailey, a specialist in geriatric pharmacy, will discuss the issue.
|